Research collaboration: Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis is a research collaboration whose article contributions are accrued to its participating partner ...

Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...

Thrombocytopenia in chronic liver disease arises from a variety of factors related to liver disease etiology, progression, and treatment. It is common in patients with cirrhosis and is a distinctive ...

Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...

Researchers have examined cellular crosstalk between the gut and liver during sepsis, helping us better understand sepsis ...

Please provide your email address to receive an email when new articles are posted on . Sustained virologic response occurred in 81.8% of patients after the first DAA treatment course. Despite this, ...

SAN DIEGO — Patients with cirrhosis treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant reductions in a range of portal hypertension complications and all-cause mortality ...

MASH patients exhibit a higher spleen-to-liver stiffness ratio than ALD patients, indicating a presinusoidal component in portal hypertension. The study found that MASH patients have larger spleen ...

Fatty Liver and High Blood Pressure: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with high blood pressure, or hypertension, but the cause-effect ...

Article ‘Count’ and ‘Share’ for Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis based on listed parameters only. The articles listed below published by authors from Christian ...

Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal hypertension (PH) being a primary driver of disease progression and ...